BeOne Medicines BEIGF
NASDAQ BEIGF
$21.95 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

BeOne Medicines (BEIGF) Treasury Shares (2015)

BeOne Medicines' (BEIGF) quarterly Treasury Shares came in at $116.8 million in Q4 2015.

Analysis

BeOne Medicines (BEIGF) Treasury Shares (2015) Analysis & Trends

BeOne Medicines (BEIGF) has reported Treasury Shares for 1 consecutive years, with $116.8 million the latest figure, recorded in Q4 2015.

  • On a quarterly basis, Treasury Shares changed N/A year-over-year to $116.8 million in Q4 2015; TTM through Dec 2015 was $116.8 million, a N/A change from a year earlier, with the FY2015 full-year figure at $116.8 million, changed N/A from the prior year.
  • Treasury Shares was $116.8 million for Q4 2015 at BeOne Medicines.
  • Over five years, Treasury Shares peaked at $116.8 million in Q4 2015 and troughed at $116.8 million in Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Johnson & Johnson 646.43 Bn 625.67 Bn 17.26 Bn 711.62 Mn
2 AbbVie 442.46 Bn 435.89 Bn 12.70 Bn 77.11 Mn
3 Merck 366.77 Bn 359.63 Bn 12.21 Bn 64.13 Bn
4 Novartis Ag 266.59 Bn 258.90 Bn 11.24 Bn -49.00 Mn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn 3.94 Bn
6 Sanofi 52.40 Bn 45.02 Bn 10.79 Bn -
7 Revolution Medicines 44.08 Bn 44.08 Bn - -
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn -
9 United Therapeutics 21.53 Bn 18.87 Bn 683.80 Mn 35.35 Mn
10 BeOne Medicines 2.48 Bn -2.62 Bn 1.53 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 116.79 Mn
Dec 31, 2015 116.79 Mn